Abstract: The present invention is concerned with 1,2,4,5-tetrahydro-benzo[d]azepin derivatives as well as with their pharmaceutically acceptable salts in their racemic and optically active form, which compounds are antagonists at metabotropic glutamate receptors and therefore useful for the treatment of diseases related to these receptors.
Type:
Grant
Filed:
August 1, 2000
Date of Patent:
April 17, 2001
Assignee:
Hoffmann-La Roche Inc.
Inventors:
Geo Adam, Alfred Binggeli, Hans-Peter Märki, Vincent Mutel, Maurice Wilhelm, Wolfgang Wostl